hsa-miR-495-3p

ncRNA information

ncRNA name

hsa-miR-495-3p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Prognosis/Treatment

Upstream regulatory factors

Not available

Downstream target

GRP78/mTOR

Cancer information

Cancer name

Gastric Cancer

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

Adriamycin/Vincristine

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR in gastric cancer.

Tissue resource

frozen paired gastric cancer patients'specimens

human gastric adenocarcinoma cell lines SGC7901

human gastric adenocarcinoma adriamycin-resistant cell lines SGC7901/ADR

human gastric adenocarcinoma vincristine-resistant cell lines SGC7901/VCR

Experiment

Western blot,Luciferase reporter assay


Institute

the First Affiliated Hospital of the Fourth Military Medical University

Country

China

Continent

Asia